Global Bioactive Wound Care Market, By Product (Moist Wound Care, Active Wound Care, Antimicrobial Wound Care), Wound Type (Surgical Wounds, Ulcers, Gunshot Wounds, Traumatic Wounds, Burns), End user (Hospitals, Trauma Centers, Armed Forces, Pharmacy Stores) – Industry Trends and Forecast to 2029.
Bioactive Wound Care Market Analysis and Size
The bioactive wound care market consists wide range of wound dressings. The wound dressings in this market are known for their biodegradable properties and their ability to fight microbial infections.
Wound infection is a major global safety concern for healthcare professionals and patients, thus effective care is essential to reduce infections. With the widespread increase in the number of patients, the demand for these products is on the rise. Rising incidence of diabetes coupled with growing aging population mainly suffer from health associated challenges such as wound healing owing to high blood sugar level in body. A resultant requirement of effective and economical dressing is likely to play a significant role in demand for bioactive wound care.
Data Bridge Market Research analyses a bioactive wound care market growth in the forecast period 2022-2029. The expected CAGR of global bioactive wound care market is tend to be around 6.90% in the mentioned forecast period. The market value is USD 5.17 billion in 2021, it seems to be USD 5.53 billion in 2021 and is expected to rise upto 8.82 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bioactive Wound Care Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Moist Wound Care, Active Wound Care, Antimicrobial Wound Care), Wound Type (Surgical Wounds, Ulcers, Gunshot Wounds, Traumatic Wounds, Burns), End user (Hospitals, Trauma Centers, Armed Forces, Pharmacy Stores)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Smith+Nephew (U.K.), Mölnlycke Health Care AB (Sweden), ConvaTec, Inc. (U.K.), Paul Hartmann AG (Germany), Organogenesis Inc. (U.S.), 3M (U.S.), Medtronic (Ireland), Covalon Technologies Limited (Canada), BSN Medical GmbH (Germany), Medline Industries, Inc. (U.S.), B. Braun Melsungen AG (Germany), Coloplast (Denmark), DermaRite Industries, LLC (U.S.), ETS Wound Care, LLC (U.S.), Hollister Incorporated (U.S.), Integra LifeSciences (U.S.), Johnson & Johnson Private Limited (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Bioactive wound care products replace traditional wound healing products. Traditionally, wound dressings have only been used to protect the wound site from contamination, but today they are more powerful in wound healing due to longer retention times at the wound site and better control of exudate. Wound dressing is widely used. Such advanced bandages have biological activity on their own or through the release of bioactive compounds contained in the bandages.
Bioactive Wound Care Market Dynamics
Drivers
- Increasing Population with Chronic and Acute Wounds
The bioactive wound care market has a large customer base around the world. Populations in many areas are vulnerable to chronic illnesses such as diabetes. Demand for bioactive wound care products can range from newborns to the elderly. The market is experiencing sloping growth due to the growing population affected by chronic and acute wounds.
- Technological Advancements in Treatment Options
The advancements in the technologies used for treating acute and chronic wounds are driving the market growth rapidly. For instance, Smith+Nephew launched the PICO 14 single-use negative pressure wound therapy system in 2020. It was aimed to minimize surgical site infections. Thus, investment in R&D and the varied launches of new wound healing products is expected to fuel the market growth.
Opportunities
- More government schemes and associated financial aid
Increased government spending on healthcare infrastructure is one of the key factors expected to drive market revenue growth during the forecast period. All these government schemes and spending are required to expand the wound care market growth as with the passing time, more and more patients are getting involved with the wound.
Restraints/Challenges
- High Cost of Bioactive Wound Care Products
Bioactive wound care products are more expensive than traditional wound care products. It is estimated that 4% of medical expenses are spent on wound care, and most of the spending is on hospital expenses. The cost of bioactive wound care products shows the impact on the overall cost of care. For instance, the price of an Organogenesis Apligraf dressing is $ 32.71 / cm. Consumers are switching to traditional wound care products due to the high cost of bioactive wound care products.
COVID-19 Impact on Bioactive Wound Care Market
The COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to influence on industry growth during the forecast period. Our ongoing research is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The pandemic has left a negative impact on the bioactive wound care market. The adoption of devices for wound care was badly affected due to the disruptive supply chain. But, in the post-pandemic era, the situation is slightly better as it again fuelled the demand and adoption of wound care products.
Market Developments
- In June 2021, ConvaTec, Inc., in collaboration with RLS Global, announced the distribution of a gentle wound debrider named Chlorasolv. It is firstly supposed to be launched in the European market, followed by the U.S. market, and later globally.
Bioactive Wound Care Market Scope
The bioactive wound care market is segmented on the basis of product, wound type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Moist Wound Care
- Alginate Wound Dressing
- Hydrocolloid Dressing
- Foam-Based Wound Dressing
- Others
- Active Wound Care
- Skin Substitutes
- Collagen Dressing
- Keratin Dressing
- Cell-based Therapy
- Others
- Antimicrobial Wound Care
- Silver-based Wound Dressing
- Iodine-based Wound Dressing
- Chitosan-based Wound Dressing
- Others
Wound Type
- Surgical Wounds
- Ulcers
- Gunshot Wounds
- Traumatic Wounds
- Burns
End User
- Hospitals
- Trauma Centers
- Armed Forces
- Pharmacy Stores
Bioactive Wound Care Regional Analysis/Insights
The bioactive wound care market is analyzed and market size insights and trends are provided by country, product, wound type and end user as referenced above.
The major countries covered in the bioactive wound care market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bioactive wound care market due to the presence of a large pool of diabetics and the rapid adoption of advanced wound care techniques.
The Asia-Pacific region is expected to witness favorable growth during the forecast period of 2022 to 2029 due to the growing target group of people with diabetic foot lesions, pressure ulcers, and infections. This allows players in this industry to run campaigns and awareness programs related to skin diseases, thereby increasing product penetration into the local industry.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Bioactive Wound Care Market Share Analysis
The bioactive woundcare market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bioactive wound care market.
Key players operating in the global bioactive wound care market include:
- Smith+Nephew (U.K.)
- Mölnlycke Health Care AB (Sweden)
- ConvaTec, Inc. (U.K.)
- Paul Hartmann AG (Germany)
- Organogenesis Inc. (U.S.)
- 3M (U.S.)
- Medtronic (Ireland)
- Covalon Technologies Limited (Canada)
- BSN Medical GmbH (Germany)
- Medline Industries, Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Coloplast (Denmark)
- DermaRite Industries, LLC (U.S.)
- ETS Wound Care, LLC (U.S.)
- Hollister Incorporated (U.S.)
- Integra LifeSciences (U.S.)
- Johnson & Johnson Private Limited (U.S.)
SKU-